Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. GRFS
GRFS logo

GRFS News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

GRFS News

Grifols Obtains FDA Approval to Introduce Fesilty in the US by Mid-2026

Dec 19 2025NASDAQ.COM

Daily Upgrade Report for Validea's Joseph Piotroski Strategy - November 26, 2025

Nov 26 2025NASDAQ.COM

Daily Upgrade Report for Validea's Joseph Piotroski Strategy - October 10, 2025

Oct 10 2025NASDAQ.COM

Everything You Should Know About Grifols (GRFS) Upgrade to Buy Rating

Aug 28 2025NASDAQ.COM

Grifols S.A. declares $0.1404 dividend

Aug 01 2025SeekingAlpha

Verona Pharma, Rhythm Pharmaceuticals, AES And Other Big Stocks Moving Higher On Wednesday

Jul 09 2025Benzinga

Analysts Anticipate KOMP To Hit $60

Jun 24 2025NASDAQ.COM

JP Morgan Maintains Neutral on Grifols, Raises Price Target to $10.3

Jun 17 2025Benzinga

GRFS Events

02/26 11:50
Grifols Expects Free Cash Flow of €500m in 2026
The company said, "For 2026, Grifols expects reaching Free Cash Flow pre-M&A pre-dividends of EUR 500m-575m, an Adjusted EBITDA margin of greater than or equal to25% with continued Adjusted EBITDA growth of 5-9% at constant currency, and a continued deleveraging path. 2027 milestones are unchanged: credit agreement leverage of 3.5x or lower by year-end 2027 and cumulative FCF pre-M&A pre-dividends (2024- 2027) of EUR 1.75-2.0bn."
02/26 11:50
Grifols Reports Q4 Revenue of €1.98B
Reports Q4 revenue EUR 1.98B, consensus EUR 1.95B. The company said, "We are confident about Grifols' highly differentiated strategy and positioning, which has been many years in the making and will support our continued margin improvement-led EBITDA growth, enhanced free cash flow generation and deleveraging path. Grifols financial and operational performance has been rewarded by strong re-rating progress across all three credit rating agencies: S&P upgraded Grifols' credit rating to 'BB-' with a 'Stable' outlook; Fitch revised the outlook to 'Positive' and affirmed the 'B+' rating; Moody's upgraded Grifols' rating to 'B1' from 'B2' with a 'Stable' outlook. All three credit rating agencies acknowledge Grifols' strong investment grade-like business characteristics."

GRFS Monitor News

No data

No data

GRFS Earnings Analysis

No Data

No Data

People Also Watch